Is there an injection for weight loss on the UK market?

Step 1: Understanding what these injections are and how they reduce weight

A question our prescribers hear most weeks is whether the injections work by suppressing willpower or by doing something more concrete. The honest answer is the latter. Mounjaro and Wegovy both mimic gut hormones that the body releases after eating. Once injected, they signal to the brain that food has arrived, slow the rate at which the stomach empties, and reduce the intensity of hunger between meals. Over time, most people eat less without experiencing the constant effort that comes with conventional calorie-restriction.

The distinction between them is meaningful. Mounjaro activates two receptors simultaneously (GIP and GLP-1) making it the only dual-agonist weight-loss medicine licensed in the UK. Wegovy targets the GLP-1 receptor only. In a head-to-head clinical trial (SURMOUNT-5, published in the New England Journal of Medicine in 2025), tirzepatide produced greater average weight loss than semaglutide 2.4 mg over 72 weeks in adults with obesity and no diabetes. Both medicines carry a Black Triangle (▼), meaning the MHRA collects additional safety data on them as real-world use grows.

If you'd like a broader overview of what weight-loss injections are available in the UK, that page sets out the options in full.

Step 2: Who the injections are licensed for, and how that shapes the prescription

Eligibility is based on the licensed indications, not on how much weight a person wants to lose. Both medicines are licensed for adults with a BMI of 30 or above, or a BMI of 27 or above where at least one weight-related health condition is present, for example, high blood pressure, high cholesterol, prediabetes, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

Age matters too. Neither injection is licensed for anyone under 18. If you are wondering about age restrictions for weight-loss injections, the position is clear: these are adult medicines, and a prescriber will ask about age at assessment. Pregnancy, breastfeeding, and planning to conceive are also circumstances where neither injection is recommended; a prescriber will go through the full picture with you.

BMI alone does not settle the question. A prescriber looks at your health history, current medicines, and any contraindications before deciding whether to approve treatment. That clinical review is the starting point, not an optional extra.

Step 3: What starting treatment actually looks like week by week

Neither injection begins at full strength. Mounjaro starts at 2.5 mg, a dose whose job is to help your body adjust, not to deliver the full therapeutic effect. It is stepped up by the prescriber, typically every four weeks, through 5, 7.5, 10, 12.5 and 15 mg. Wegovy follows a similar ladder: 0.25 mg rising through 0.5, 1.0, 1.7 and 2.4 mg, with a 7.2 mg option now also MHRA-approved for eligible patients. The gradual titration exists because most of the gastrointestinal side effects (nausea, loose stools, indigestion) are dose-related and tend to settle as the body adapts.

Injections go under the skin of the abdomen, thigh, or upper arm, rotating the site each week. You can read about the UK clinical trial evidence behind these medicines if you want to understand the data before deciding. For context on how much the injections typically cost through a private UK service, the cost of weight-loss injections page sets out what the market currently looks like and what a legitimate price includes.

Practical detail matters here. Safe disposal of used pens is a legal requirement; a sharps container is the appropriate way to dispose of them. Your prescriber will cover this at the point of approval.

Step 4: The private route through a regulated UK pharmacy, and what to watch for online

On the NHS, access to both injections is available but phased and subject to strict criteria. Many people who are clinically eligible either don't meet the current NHS thresholds or prefer not to join a waiting list. A private prescription from a GPhC-registered online pharmacy is the legal alternative. The process involves a clinical consultation, identity and weight verification, a prescriber review, and then dispensing through the licensed UK supply chain.

Worth knowing: the MHRA has issued repeated warnings about fake weight-loss pens sold through social media and unverified websites. Counterfeit pens have contained incorrect substances, including insulin, and have caused serious harm. The safe check is simple, any online pharmacy dispensing prescription medicines in the UK must appear on the GPhC register of pharmacies. If a seller is offering these medicines without asking you to complete a clinical assessment, that is a red flag, not a convenience.

For a broader look at all the options currently available, the weight-loss injections guide covers licensing, access routes and what to expect. And if injecting isn't something you want to explore, there is now also a licensed oral option worth knowing about, weight-loss pill alternatives to injection explains what's currently approved in the UK.

If you'd like a prescriber to review whether either injection is suitable for you, start your free consultation and a GPhC-registered Independent Prescriber will assess your case the same day.